מיפג'ין

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

MIFEPRISTONE

제공처:

A. LAPIDOT PHARMACEUTICALS, LTD

ATC 코드:

G03XB01

약제 형태:

טבליה

구성:

MIFEPRISTONE 200 MG

관리 경로:

פומי

처방전 유형:

מרשם נדרש

Manufactured by:

EXELGYNE LABORATORIES, FRANCE

치료 그룹:

MIFEPRISTONE

치료 영역:

MIFEPRISTONE

치료 징후:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

승인 날짜:

2014-07-31